Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14611893rdf:typepubmed:Citationlld:pubmed
pubmed-article:14611893lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:14611893lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:14611893lifeskim:mentionsumls-concept:C0770595lld:lifeskim
pubmed-article:14611893lifeskim:mentionsumls-concept:C0814997lld:lifeskim
pubmed-article:14611893lifeskim:mentionsumls-concept:C0017977lld:lifeskim
pubmed-article:14611893lifeskim:mentionsumls-concept:C0596577lld:lifeskim
pubmed-article:14611893lifeskim:mentionsumls-concept:C0031164lld:lifeskim
pubmed-article:14611893lifeskim:mentionsumls-concept:C0870883lld:lifeskim
pubmed-article:14611893lifeskim:mentionsumls-concept:C0220014lld:lifeskim
pubmed-article:14611893pubmed:issue2-3lld:pubmed
pubmed-article:14611893pubmed:dateCreated2003-11-12lld:pubmed
pubmed-article:14611893pubmed:abstractTextThe present investigation focused on the transepithelial flux of liquiritigenin (LG), davidigenin (DG), liquiritin (LQ), and liquiritin apioside (LA) using the human colonic cell line Caco-2 as a model of human intestinal absorption. Apparent permeability coefficients (Papp) for the apical to basolateral flux of LG and DG were (16.0 +/- 0.727) x 10(-6) cm/s and (18.2 +/- 1.67) x 10(-6) cm/s, respectively. These Papp were higher than that of the transcellular transport marker propranolol (13.5 +/- 0.34) x 10(-6) cm/s (P < 0.01). Papp for the apical to basolateral flux of LQ and LA were (0.26 +/- 0.12) x 10(-6) cm/s and (0.075 +/- 0.005) x 10(-6) cm/s, respectively. These Papp were lower than that of the paracellular transport marker mannitol (0.64 +/- 0.04) x 10(-6) cm/s (LG, P < 0.01; LA, P < 0.001). These data suggested excellent absorption of LG and DG through the human intestinal epithelial cell line. On the contrary, poor absorption of LQ and LA was expected due to the little transepithelial flux of these compounds in the human colonic cell line Caco-2.lld:pubmed
pubmed-article:14611893pubmed:languageenglld:pubmed
pubmed-article:14611893pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14611893pubmed:citationSubsetIMlld:pubmed
pubmed-article:14611893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14611893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14611893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14611893pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14611893pubmed:statusMEDLINElld:pubmed
pubmed-article:14611893pubmed:monthDeclld:pubmed
pubmed-article:14611893pubmed:issn0378-8741lld:pubmed
pubmed-article:14611893pubmed:authorpubmed-author:AsanoTakayuki...lld:pubmed
pubmed-article:14611893pubmed:authorpubmed-author:IshiharaKazuh...lld:pubmed
pubmed-article:14611893pubmed:authorpubmed-author:TakedaShuichi...lld:pubmed
pubmed-article:14611893pubmed:authorpubmed-author:MorotaTakashi...lld:pubmed
pubmed-article:14611893pubmed:authorpubmed-author:AburadaMasaki...lld:pubmed
pubmed-article:14611893pubmed:issnTypePrintlld:pubmed
pubmed-article:14611893pubmed:volume89lld:pubmed
pubmed-article:14611893pubmed:ownerNLMlld:pubmed
pubmed-article:14611893pubmed:authorsCompleteYlld:pubmed
pubmed-article:14611893pubmed:pagination285-9lld:pubmed
pubmed-article:14611893pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:14611893pubmed:meshHeadingpubmed-meshheading:14611893...lld:pubmed
pubmed-article:14611893pubmed:meshHeadingpubmed-meshheading:14611893...lld:pubmed
pubmed-article:14611893pubmed:meshHeadingpubmed-meshheading:14611893...lld:pubmed
pubmed-article:14611893pubmed:meshHeadingpubmed-meshheading:14611893...lld:pubmed
pubmed-article:14611893pubmed:meshHeadingpubmed-meshheading:14611893...lld:pubmed
pubmed-article:14611893pubmed:meshHeadingpubmed-meshheading:14611893...lld:pubmed
pubmed-article:14611893pubmed:meshHeadingpubmed-meshheading:14611893...lld:pubmed
pubmed-article:14611893pubmed:meshHeadingpubmed-meshheading:14611893...lld:pubmed
pubmed-article:14611893pubmed:meshHeadingpubmed-meshheading:14611893...lld:pubmed
pubmed-article:14611893pubmed:meshHeadingpubmed-meshheading:14611893...lld:pubmed
pubmed-article:14611893pubmed:year2003lld:pubmed
pubmed-article:14611893pubmed:articleTitlePermeability of the flavonoids liquiritigenin and its glycosides in licorice roots and davidigenin, a hydrogenated metabolite of liquiritigenin, using human intestinal cell line Caco-2.lld:pubmed
pubmed-article:14611893pubmed:affiliationDepartment of Drug Metabolism and Disposition, Tsumura Research Institute, Tsumura & Co., 3586 Yoshiwara, Ami-machi, Inashiki-gun, Ibaraki 300-1192, Japan. asano_takayuki2@mail.tsumura.co.jplld:pubmed
pubmed-article:14611893pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14611893pubmed:publicationTypeComparative Studylld:pubmed